← Leaderboards
Thomas Edward Von Wiegand
Sensimetrics Corporation
$1,389,020
Attributed
$1,389,020
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $275.8K · FY2005–24$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,389,020 · 6
By mechanism
R43$950,223 · 5
R03$438,797 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchBiomedical Equipment DevelopmentPortable Biomedical EquipmentHuman SubjectBiosensor DeviceSpace PerceptionBehavioral /Social Science Research TagVision DisordersCuesChordate LocomotionAssistive Device /TechnologyVision AidResearch StudyPrototypeAcousticsPublic Health RelevanceSpeechPerformanceHeadGovernmentHearingNoisePersonsDesign
Grant awards (8)
Non-metallic earbuds for auditory stimuli in MRI scanners$275,765
R43 · FY2024 · DC · contact PI
CONVERSATION ASSISTANT FOR NOISY ENVIRONMENTS$151,032
R43 · FY2009 · DC · contact PI
A WIRELESS SELF-CONTAINED TACTILE AID$135,240
R43 · FY2006 · DC · contact PI
Portable Standardization Tool for Erectile Dysfunction$188,445
R43 · FY2005 · DK
Female Sexual Dysfunction diagnostic Tool Development$199,741
R43 · FY2004 · DK
Haptic display of space through portable nav aids$150,968
R03 · FY2004 · EY
Haptic display of space through portable nav aids$149,962
R03 · FY2003 · EY
Haptic display of space through portable nav aids$137,867
R03 · FY2002 · EY